These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33620285)

  • 1. The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB-IVA cervical cancer.
    Deng C; Ding D; Wang M
    Postgrad Med; 2021 May; 133(4):436-443. PubMed ID: 33620285
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
    Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS
    Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
    Vural GU; Akkas BE; Demirel BB
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
    Crivellaro C; Signorelli M; Guerra L; De Ponti E; Buda A; Dolci C; Pirovano C; Todde S; Fruscio R; Messa C
    Gynecol Oncol; 2012 Oct; 127(1):131-5. PubMed ID: 22772064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
    Li K; Sun H; Guo Q
    Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L; Mucientes-Rasilla J; San-Frutos Llorente LM; Royuela A; Garcia-Espantaleón Navas M; Herrero Gámiz S; Pérez-Medina T
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):17-21. PubMed ID: 30366731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic parameters of [
    Markus M; Sartor H; Bjurberg M; Trägårdh E
    Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
    Leseur J; Roman-Jimenez G; Devillers A; Ospina-Arango JD; Williaume D; Castelli J; Terve P; Lavoue V; Garin E; Lejeune F; Acosta O; De Crevoisier R
    Radiother Oncol; 2016 Sep; 120(3):512-518. PubMed ID: 27569847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer.
    Yang Z; Xu W; Ma Y; Liu K; Li Y; Wang D
    Eur J Radiol; 2016 May; 85(5):877-84. PubMed ID: 27130046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
    J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY; Guo Z; Sun J; Yang WP; Li TR
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
    [No Abstract]   [Full Text] [Related]  

  • 13. The feasibility of
    Liu S; Xia L; Yang Z; Ge H; Wang C; Pan H; Song S; Zhou Z
    Cancer Imaging; 2020 Sep; 20(1):63. PubMed ID: 32912310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
    Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Intratumoral Metabolic Heterogeneity and Quantitative
    Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
    AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
    Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.